Promoter Hypermethylation Promotes the Binding of Transcription Factor NFATc1, Triggering Oncogenic Gene Activation in Pancreatic Cancer.

gene regulation pancreatic ductal adenocarcinoma promoter methylation transcription factors

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
11 Sep 2021
Historique:
received: 08 04 2021
revised: 14 05 2021
accepted: 08 09 2021
entrez: 28 9 2021
pubmed: 29 9 2021
medline: 29 9 2021
Statut: epublish

Résumé

Studies have indicated that some genes involved in carcinogenesis are highly methylated in their promoter regions but nevertheless strongly transcribed. It has been proposed that transcription factors could bind specifically to methylated promoters and trigger transcription. We looked at this rather comprehensively for pancreatic ductal adenocarcinoma (PDAC) and studied some cases in more detail. Some 2% of regulated genes in PDAC exhibited higher transcription coupled to promoter hypermethylation in comparison to healthy tissue. Screening 661 transcription factors, several were found to bind specifically to methylated promoters, in particular molecules of the NFAT family. One of them-NFATc1-was substantially more strongly expressed in PDAC than control tissue and exhibited a strong oncogenic role. Functional studies combined with computational analyses allowed determining affected genes. A prominent one was gene

Identifiants

pubmed: 34572796
pii: cancers13184569
doi: 10.3390/cancers13184569
pmc: PMC8471171
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Sci Rep. 2017 Jan 03;7:39756
pubmed: 28045055
Am J Pathol. 1998 Jul;153(1):263-9
pubmed: 9665487
Science. 2017 May 5;356(6337):
pubmed: 28473536
Elife. 2017 May 29;6:
pubmed: 28553926
Cell Death Dis. 2016 Apr 21;7:e2199
pubmed: 27100893
Annu Rev Immunol. 1997;15:707-47
pubmed: 9143705
Nat Rev Genet. 2016 Aug 1;17(9):551-65
pubmed: 27479905
Gastroenterology. 2017 May;152(6):1507-1520.e15
pubmed: 28188746
Cell Res. 2012 Jan;22(1):90-106
pubmed: 21876555
J Biol Chem. 2010 Aug 27;285(35):27241-27250
pubmed: 20516082
Int J Cancer. 2020 Jul 1;147(1):189-201
pubmed: 31846072
Nat Rev Genet. 2012 May 29;13(7):484-92
pubmed: 22641018
Genes Dev. 2003 Sep 15;17(18):2205-32
pubmed: 12975316
Nucleic Acids Res. 2018 Jan 4;46(D1):D146-D151
pubmed: 29145608
Cell Res. 2013 Nov;23(11):1256-69
pubmed: 23938295
Elife. 2013 Sep 03;2:e00726
pubmed: 24015356
Epigenetics. 2006 Jul-Sep;1(3):127-30
pubmed: 17965610
J Cell Sci. 2001 Jul;114(Pt 13):2363-73
pubmed: 11559745
Gastroenterology. 2015 May;148(5):1024-1034.e9
pubmed: 25623042
Sci Rep. 2016 Nov 23;6:37652
pubmed: 27876874
Trends Cancer. 2020 May;6(5):392-406
pubmed: 32348735
Nature. 1998 May 28;393(6683):386-9
pubmed: 9620804
Bioinformatics. 2011 Apr 1;27(7):1017-8
pubmed: 21330290
Int J Cancer. 2016 Sep 1;139(5):965-75
pubmed: 26991532
Cell. 1991 Mar 22;64(6):1123-34
pubmed: 2004419
Exp Cell Res. 2020 Jan 1;386(1):111713
pubmed: 31705846
EMBO J. 2006 Aug 9;25(15):3714-24
pubmed: 16874304
Trends Endocrinol Metab. 2000 May-Jun;11(4):142-8
pubmed: 10754536
Biochim Biophys Acta. 2012 Jul;1819(7):763-70
pubmed: 22387149
Nature. 2018 Mar 22;555(7697):469-474
pubmed: 29539639
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Nat Commun. 2019 Aug 28;10(1):3875
pubmed: 31462645
Nat Genet. 2003 Mar;33 Suppl:245-54
pubmed: 12610534
Nat Protoc. 2019 Mar;14(3):703-721
pubmed: 30804569
Epigenetics. 2018;13(7):751-768
pubmed: 30058478
Int J Cancer. 2018 Mar 1;142(5):1010-1021
pubmed: 28983920
Cancer Cell. 2017 Aug 14;32(2):185-203.e13
pubmed: 28810144
Nat Rev Gastroenterol Hepatol. 2018 Jun;15(6):333-348
pubmed: 29717230
Discov Med. 2014 Feb;17(92):67-73
pubmed: 24534469
Nat Methods. 2014 Nov;11(11):1138-1140
pubmed: 25262207
Nat Genet. 2007 Apr;39(4):457-66
pubmed: 17334365
Bio Protoc. 2019 Feb 05;9(3):e3152
pubmed: 33654961
Biol Methods Protoc. 2020 Feb 10;5(1):bpaa005
pubmed: 32395634
Nucleic Acids Res. 2019 Jan 8;47(D1):D330-D338
pubmed: 30395331
Bioinformatics. 2005 Nov 1;21(21):4067-8
pubmed: 16141249
Cell. 2015 Apr 23;161(3):555-568
pubmed: 25892221

Auteurs

Yenan Wu (Y)

Division of Functional Genome Analysis, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, 69120 Heidelberg, Germany.
Faculty of Biosciences, Heidelberg University, Im Neuenheimer Feld, 69120 Heidelberg, Germany.

Lea Kröller (L)

Division of Functional Genome Analysis, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, 69120 Heidelberg, Germany.
Faculty of Biosciences, Heidelberg University, Im Neuenheimer Feld, 69120 Heidelberg, Germany.

Beiping Miao (B)

Division of Functional Genome Analysis, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, 69120 Heidelberg, Germany.
Medical Faculty Heidelberg, Heidelberg University, Im Neuenheimer Feld, 69120 Heidelberg, Germany.

Henning Boekhoff (H)

Division of Functional Genome Analysis, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, 69120 Heidelberg, Germany.
Faculty of Biosciences, Heidelberg University, Im Neuenheimer Feld, 69120 Heidelberg, Germany.

Andrea S Bauer (AS)

Division of Functional Genome Analysis, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, 69120 Heidelberg, Germany.

Markus W Büchler (MW)

Department of General Surgery, University Hospital Heidelberg, Im Neuenheimer Feld 420, 69120 Heidelberg, Germany.

Thilo Hackert (T)

Department of General Surgery, University Hospital Heidelberg, Im Neuenheimer Feld 420, 69120 Heidelberg, Germany.

Nathalia A Giese (NA)

Department of General Surgery, University Hospital Heidelberg, Im Neuenheimer Feld 420, 69120 Heidelberg, Germany.

Jussi Taipale (J)

Division of Functional Genomics, Department of Medical Biochemistry and Biophysics, Karolinska Institute, 171 65 Solna, Sweden.

Jörg D Hoheisel (JD)

Division of Functional Genome Analysis, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, 69120 Heidelberg, Germany.

Classifications MeSH